Hearing ‐ mean final hearing threshold (4 months ‐ medium‐term) № of participants: 125 (1 RCT) · children aged 6 months to 12 years with otitis media with effusion (OME)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Hospital length of stay · patients admitted to hospital with a medical condition (27 trials), with a mix of medical and surgical conditions (4 trials), following a…
The intervention showed no clear difference in hospital length of stay (moderate certainty).
1 finding from 1 review
Intervention not reported
Unscheduled readmission · patients admitted to hospital with a medical condition (27 trials), with a mix of medical and surgical conditions (4 trials), following a…
The intervention probably leads to lower unscheduled readmission (moderate certainty).
1 finding from 1 review
Intervention not reported
Patient health status · patients admitted to hospital with a medical condition (27 trials), with a mix of medical and surgical conditions (4 trials), following a…
1 finding from 1 review
Intervention not reported
Satisfaction of patients, care givers and healthcare professionals · patients admitted to hospital with a medical condition (27 trials), with a mix of medical and surgical conditions (4 trials), following a…
It is very uncertain whether the intervention changes satisfaction of patients, care givers and healthcare professionals (very low certainty).
1 finding from 1 review
Intervention not reported
Healthcare resource use and costs · patients admitted to hospital with a medical condition (27 trials), with a mix of medical and surgical conditions (4 trials), following a…
It is very uncertain whether the intervention changes healthcare resource use and costs (very low certainty).
1 finding from 1 review
Self‐reported shoulder function: Croft Shoulder Disability Score (1 or more problems) · adults with minimally displaced or displaced (2‐part or 3‐part) proximal humeral fractures treated non‐surgically (5 trials)
It is very uncertain whether early changes self‐reported shoulder function: Croft Shoulder Disability Score (1… compared with delayed mobilisation (very low certainty).
2 findings from 1 review
Self‐reported shoulder function · adults with minimally displaced or displaced (2‐part or 3‐part) proximal humeral fractures treated non‐surgically (5 trials)
1 finding from 1 review
Quality of life: EQ‐5D (0: dead to 1: best quality of life) · adults with minimally displaced or displaced (2‐part or 3‐part) proximal humeral fractures treated non‐surgically (5 trials)
1 finding from 1 review
All‐cause mortality · adults with minimally displaced or displaced (2‐part or 3‐part) proximal humeral fractures treated non‐surgically (5 trials)
1 finding from 1 review
Adverse events: Shoulder complications · adults with minimally displaced or displaced (2‐part or 3‐part) proximal humeral fractures treated non‐surgically (5 trials)
1 finding from 1 review
Additional surgery or substantive treatment · adults with minimally displaced or displaced (2‐part or 3‐part) proximal humeral fractures treated non‐surgically (5 trials)
1 finding from 1 review
Intervention not reported
Cognitive function using validated neuropsychological tests · patients with a primary brain tumour, within two weeks of surgical intervention
1 finding from 1 review
Red blood cell transfusions (Subnet based on 69 studies including 18,684 participants) · cardiac surgery for the treatment of non‐surgical bleeding
1 finding from 1 review
Blood products transfused (RBC) % of patients · cardiac surgery for the treatment of non‐surgical bleeding
It is very uncertain whether PCC changes blood products transfused (RBC) % of patients compared with FVIIa (very low certainty).
1 finding from 1 review
All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) · cardiac surgery for the treatment of non‐surgical bleeding
It is very uncertain whether PCC changes thrombotic events compared with FVIIa (very low certainty).
1 finding from 1 review
Mortality (30‐day) · cardiac surgery for the treatment of non‐surgical bleeding
It is very uncertain whether PCC changes mortality (30‐day) compared with FVIIa (very low certainty).
1 finding from 1 review
Bleeding (chest drain output) in mLs for the first 12 hours · cardiac surgery for the treatment of non‐surgical bleeding
1 finding from 1 review
Length of critical care stay (hours) · cardiac surgery for the treatment of non‐surgical bleeding
1 finding from 1 review
Incidence of renal impairment · cardiac surgery for the treatment of non‐surgical bleeding
It is very uncertain whether PCC changes incidence of renal impairment compared with FVIIa (very low certainty).
1 finding from 1 review